Skip links

SNMMI Annual Meeting, May 30-June 02, 2026, Los Angeles, US

We are happy to share that our CEO Randolf Kerschbaumer is attending SNMMI Annual Meeting taking place in Los Angeles from May 30 to June 2, 2026. 

OncoOne’s platform for pre-targeted radioimmunotherapy has been developed to improve treatment outcomes for patients with solid tumors. Randolf would be delighted to discuss strategic collaborations with partners who share our commitment to advancing cancer treatment.